An editorial is presented on a possible explanation for the contrasting results of REDUCE-IT vs. STRENGTH: cohort study mimicking trial designs. Topics include reducing biomarkers of chronic inflammation such as C-reactive protein (CRP), tumour necrosis factor-a, and proinflammatory eicosanoids and leukotrienes; and estimate effects of the observed changes in circulating levels of three biomarkers.